Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 890

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 890
---
 The Company Board has unanimously adopted resolutions (i) determining that this
Agreement, the Mergers and the other transactions contemplated hereby are fair to and in the best interests of the Company and its stockholders, (ii) subject to , approving and declaring advisable this
Agreement and the transactions contemplated hereby, including the Mergers, (iii) resolving to recommend that the Company’s stockholders adopt this Agreement (this , the “”) and
(iv) approving this Agreement and the transactions contemplated hereby for purposes of Section 203 of the DGCL, which resolutions have not been subsequently rescinded, modified or withdrawn in any way, except as may be permitted by
.

Section 3.4 .

(a) The execution, delivery and performance of this Agreement by the Company does not, and the consummation of the Mergers and the other
transactions contemplated hereby and compliance by the Company with the provisions hereof will not, (i) conflict with or violate the Company Charter or Company Bylaws or the equivalent organizational documents of any of the Company’s
Subsidiaries, (ii) assuming that all consents, approvals and authorizations contemplated by through of below have been obtained and all filings
described in such clauses have been made, conflict with or violate any law, statute, treaty, rule, regulation, order, ordinance, writ, ruling, judgment, decree or binding determination of any arbitrator, court or Governmental Entity (collectively,
“”) applicable to the Company or any of its Subsidiaries or by which any of their respective properties are bound or (iii) result in any breach or violation of, or constitute a default (or an event which with notice or lapse
of time or both would become a default), or result in the loss of a benefit under, or give rise to any right of termination, cancellation, amendment or acceleration of, any note, bond, mortgage, indenture, contract, agreement, lease, license, permit
or other instrument or obligation (each (but for the sake of clarification, excluding purchase orders), a “”) to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries or
any of their respective properties are bound, except, in the case of and , for any such conflict, breach, violation, default, loss, right or other occurrence that would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect.

(b)